Bishal Singh
Bharat Express News Network
Nasha Mukt Punjab Yatra: Amit Shah To Address BJP’s Concluding Programme In Jalandhar
Amit Shah will address the BJP’s Nasha Mukt Punjab Yatra finale in Jalandhar after the campaign covered 117 constituencies and nearly 4,000 km.
Supreme Court Declines PIL Seeking Central Law To Tackle School Bullying, Ragging
The Supreme Court declines a PIL seeking a central law and uniform guidelines to tackle bullying and ragging in schools across India.
Asian Games 2026: PM Modi, Amit Shah Congratulate Manisha Keer, Neeru, Aashima Ahlawat
PM Modi and Amit Shah congratulate Manisha Keer, Neeru and Aashima Ahlawat after their Women’s Trap Team silver at the Asian Games 2026.
India Target Series Victory As West Indies Clash Moves To Guwahati
India head to the second ODI against the West Indies in Guwahati on Wednesday aiming to take the series, after a successful chase.
Asian Games 2026: PM Modi, Amit Shah Congratulate Neeru Dhanda On Historic Trap Gold
PM Modi and Amit Shah congratulate Neeru Dhanda on her historic Women’s Trap gold and record-setting performance at the Asian Games 2026.
Adani Ahmedabad Marathon 2026: Harsh Sanghavi Extends Support For 10th Edition
Harsh Sanghavi backs the 10th Adani Ahmedabad Marathon on November 29, which will continue its #Run4OurSoldiers initiative honouring the Armed Forces.
Asian Games 2026: Amit Shah Congratulates Esha Singh On 25m Pistol Silver
Amit Shah congratulates Esha Singh on winning silver in the women’s 25m pistol event at the Asian Games 2026.
Old EVM Protest Video Resurfaces As Recent Jantar Mantar Demonstration: PIB Fact Check
A viral video claimed to show a recent EVM protest at Jantar Mantar. PIB Fact Check says the footage is from January 2024.
Kohli Credits India’s Winning Mindset For His Enduring ODI Career
Virat Kohli says team success, rather than personal records, has guided his international career after he crossed 15,000 ODI runs.
Rs 78,468 A Month For A Cancer Drug: Kerala HC Asks Centre To Explore Patent Law
Kerala HC asks the Centre to assess Section 100 of the Patents Act to expand access to expensive patented medicines, including Ribociclib.
